The association between diabetes related medical costs and glycemic control: A retrospective analysis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The objective of this research is to quantify the association between direct medical costs attributable to type 2 diabetes and level of glycemic control. Methods: A longitudinal analysis using a large health plan administrative database was performed. The index date was defined as the first date of diabetes diagnosis and individuals had to have at least two HbA1c values post index date in order to be included in the analyses. A total of 10,780 individuals were included in the analyses. Individuals were stratified into groups of good (N = 6,069), fair (N = 3,586), and poor (N = 1,125) glycemic control based upon mean HbA1c values across the study period. Differences between HbA1c groups were analyzed using a generalized linear model (GLM), with differences between groups tested by utilizing z-statistics. The analyses allowed a wide range of factors to affect costs. Results: 42.1% of those treated only with oral agents, 66.1% of those treated with oral agents and insulin, and 57.2% of those treated with insulin alone were found to have suboptimal control (defined as fair or poor) throughout the study period (average duration of follow-up was 2.95 years). Results show that direct medical costs attributable to type 2 diabetes were 16% lower for individuals with good glycemic control than for those with fair control ($1,505 vs. $1,801, p < 0.05), and 20% lower for those with good glycemic control than for those with poor control ($1,505 vs. $1,871, p < 0.05). Prescription drug costs were also significantly lower for individuals with good glycemic control compared to those with fair ($377 vs. $465, p < 0.05) or poor control ($377 vs. $423, p < 0.05). Conclusion: Almost half (44%) of all patients diagnosed with type 2 diabetes are at sub-optimal glycemic control. Evidence from this analysis indicates that the direct medical costs of treating type 2 diabetes are significantly higher for individuals who have fair or poor glycemic control than for those who have good glycemic control. Patients under fair control account for a greater proportion of the cost burden associated with antidiabetic prescription drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
A desktop guide to Type 2 diabetes mellitus
European Diabetes Policy Group, 1. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00166.x · Cited by 670
Management of dyslipidemia in children and adolescents with diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2194 · Cited by 438
Cited by
Muka, T., Imo, D., Jaspers, L., Colpani, V., Chaker, L., van der Lee, S. J., Mendis, S., Chowdhury, R., Bramer, W. M., Falla, A., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-014-9984-2 · Cited by 373
Parkhurst, J. (2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · doi:10.4324/9781315675008 · Cited by 756
Medication adherence and glycemic control among newly diagnosed diabetes patients
Lin, L.-K., Sun, Y., Heng, B. H., Chew, D. E. K., & Chong, P.-N. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000429 · Cited by 123
Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia
Fiseha, T., Alemayehu, E., Kassahun, W., Adamu, A., & Gebreweld, A. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3423-5 · Cited by 106
Metadata
- Authors
- Oglesby, A. K., Secnik, K., Barron, J., Al-Zakwani, I., & Lage, M. J.
- Venue
- Cost Effectiveness and Resource Allocation
- Published
- 2006-01-16
- Volume
- 4
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1478-7547 (ISSN-L)
- OpenAlex
- W2099621347
- Cited by
- 136
- References
- 4
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between diabetes related medical costs and glycemic control: A retrospective analysis. https://app.cochat.ai/papers/10.1186/1478-7547-4-1
- The paper
- Oglesby, A. K., Secnik, K., Barron, J., Al-Zakwani, I., & Lage, M. J. (2006). The association between diabetes related medical costs and glycemic control: A retrospective analysis. Cost Effectiveness and Resource Allocation. https://doi.org/10.1186/1478-7547-4-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.